Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 45,930 $ 62,937
Restricted cash 185 185
Accounts receivable, net of allowance of $308 and $309 as of March 31, 2022 and December 31, 2021, respectively 49,788 57,980
Inventory 18,982 17,217
Prepaid expenses and other current assets 18,740 18,833
Total current assets 133,625 157,152
Property, plant and equipment, net 7,711 7,741
Goodwill 13,641 13,641
Intangible assets, net 6,154 6,438
Right-of-use assets, net 5,957 6,585
Other non-current assets 3,854 3,942
Total assets 170,942 195,499
Current liabilities:    
Accounts payable 28,621 29,709
Deferred revenue 3,219 2,902
Accrued expenses 25,537 26,967
Senior term loan, current portion 3,577 3,187
Subordinated debt 10,707 10,577
Current portion of long-term debt 272 275
Total current liabilities 71,933 73,617
Subordinated term loan - related party 38,834 37,991
Senior term loan 37,702 37,876
Convertible debt 41,970 41,343
Other long-term liabilities 19,929 20,924
Total liabilities 210,368 211,751
Stockholders’ deficit:    
Common stock, $0.0001 par value; 250,000,000 shares authorized; 72,335,952 shares issued and outstanding as of March 31, 2022 and December 31, 2021 7 7
Additional paid-in capital 756,156 749,592
Accumulated deficit (795,589) (765,851)
Total stockholders’ deficit (39,426) (16,252)
Total liabilities and stockholders’ deficit $ 170,942 $ 195,499